Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers.

Brunner AL, Beck AH, Edris B, Sweeney RT, Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, Foley JW, Witten DM, Giacomini CP, Flynn RA, Pollack JR, Tibshirani R, Chang HY, van de Rijn M, West RB.

Genome Biol. 2012 Aug 28;13(8):R75. doi: 10.1186/gb-2012-13-8-r75.

2.

Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes.

Reiche K, Kasack K, Schreiber S, Lüders T, Due EU, Naume B, Riis M, Kristensen VN, Horn F, Børresen-Dale AL, Hackermüller J, Baumbusch LO.

PLoS One. 2014 Sep 29;9(9):e106076. doi: 10.1371/journal.pone.0106076. eCollection 2014.

3.
4.

Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer.

White NM, Cabanski CR, Silva-Fisher JM, Dang HX, Govindan R, Maher CA.

Genome Biol. 2014 Aug 13;15(8):429. doi: 10.1186/s13059-014-0429-8.

5.

Genome-wide transcript profiling reveals novel breast cancer-associated intronic sense RNAs.

Kim SW, Fishilevich E, Arango-Argoty G, Lin Y, Liu G, Li Z, Monaghan AP, Nichols M, John B.

PLoS One. 2015 Mar 23;10(3):e0120296. doi: 10.1371/journal.pone.0120296. eCollection 2015.

6.

Identification of large intergenic non-coding RNAs in bovine muscle using next-generation transcriptomic sequencing.

Billerey C, Boussaha M, Esquerré D, Rebours E, Djari A, Meersseman C, Klopp C, Gautheret D, Rocha D.

BMC Genomics. 2014 Jun 19;15:499. doi: 10.1186/1471-2164-15-499.

7.

A transcriptional sketch of a primary human breast cancer by 454 deep sequencing.

Guffanti A, Iacono M, Pelucchi P, Kim N, Soldà G, Croft LJ, Taft RJ, Rizzi E, Askarian-Amiri M, Bonnal RJ, Callari M, Mignone F, Pesole G, Bertalot G, Bernardi LR, Albertini A, Lee C, Mattick JS, Zucchi I, De Bellis G.

BMC Genomics. 2009 Apr 20;10:163. doi: 10.1186/1471-2164-10-163.

8.

Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs.

Hackermüller J, Reiche K, Otto C, Hösler N, Blumert C, Brocke-Heidrich K, Böhlig L, Nitsche A, Kasack K, Ahnert P, Krupp W, Engeland K, Stadler PF, Horn F.

Genome Biol. 2014 Mar 4;15(3):R48. doi: 10.1186/gb-2014-15-3-r48.

9.

Identification of novel transcripts and noncoding RNAs in bovine skin by deep next generation sequencing.

Weikard R, Hadlich F, Kuehn C.

BMC Genomics. 2013 Nov 14;14:789. doi: 10.1186/1471-2164-14-789.

10.

Long intergenic non-coding RNAs (LincRNAs) identified by RNA-seq in breast cancer.

Ding X, Zhu L, Ji T, Zhang X, Wang F, Gan S, Zhao M, Yang H.

PLoS One. 2014 Aug 1;9(8):e103270. doi: 10.1371/journal.pone.0103270. eCollection 2014.

11.

Targeting long non-coding RNAs in cancers: progress and prospects.

Li CH, Chen Y.

Int J Biochem Cell Biol. 2013 Aug;45(8):1895-910. doi: 10.1016/j.biocel.2013.05.030. Epub 2013 Jun 4. Review.

PMID:
23748105
12.

Functional significance of long non-coding RNAs in breast cancer.

Vikram R, Ramachandran R, Abdul KS.

Breast Cancer. 2014 Sep;21(5):515-21. doi: 10.1007/s12282-014-0554-y. Epub 2014 Jul 20. Review.

PMID:
25038622
13.

Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer.

Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC, Reis EM.

Mol Cancer. 2011 Nov 13;10:141. doi: 10.1186/1476-4598-10-141.

14.

Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification.

Akrami R, Jacobsen A, Hoell J, Schultz N, Sander C, Larsson E.

PLoS One. 2013 Nov 12;8(11):e80306. doi: 10.1371/journal.pone.0080306. eCollection 2013.

15.

Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers.

Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, Fan L, Kandalaft LE, Tanyi JL, Li C, Yuan CX, Zhang D, Yuan H, Hua K, Lu Y, Katsaros D, Huang Q, Montone K, Fan Y, Coukos G, Boyd J, Sood AK, Rebbeck T, Mills GB, Dang CV, Zhang L.

Cancer Cell. 2015 Oct 12;28(4):529-40. doi: 10.1016/j.ccell.2015.09.006.

PMID:
26461095
16.

Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancer.

Chen C, Li Z, Yang Y, Xiang T, Song W, Liu S.

Cancer Biol Ther. 2015;16(6):856-65. doi: 10.1080/15384047.2015.1040957.

17.

Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancers.

Kang L, Sun J, Wen X, Cui J, Wang G, Hoffman AR, Hu JF, Li W.

Eur J Cancer. 2015 Jan;51(2):260-70. doi: 10.1016/j.ejca.2014.10.031. Epub 2014 Nov 20.

PMID:
25465188
18.

Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer.

Bawa P, Zackaria S, Verma M, Gupta S, Srivatsan R, Chaudhary B, Srinivasan S.

PLoS One. 2015 May 1;10(5):e0122143. doi: 10.1371/journal.pone.0122143. eCollection 2015.

19.

Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM).

Wright CM, Kirschner MB, Cheng YY, O'Byrne KJ, Gray SG, Schelch K, Hoda MA, Klebe S, McCaughan B, van Zandwijk N, Reid G.

PLoS One. 2013 Aug 19;8(8):e70940. doi: 10.1371/journal.pone.0070940. eCollection 2013.

20.

LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer.

Shen Y, Wang Z, Loo LW, Ni Y, Jia W, Fei P, Risch HA, Katsaros D, Yu H.

Breast Cancer Res Treat. 2015 Dec;154(3):473-82. doi: 10.1007/s10549-015-3632-8. Epub 2015 Nov 13.

PMID:
26564482
Items per page

Supplemental Content

Write to the Help Desk